Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Parenteral Nutrition Market

Parenteral Nutrition Market Size

Report ID: GMI3216
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Parenteral Nutrition Market Size

Parenteral Nutrition Market was valued at USD 5.7 billion in 2022 and is projected to grow at a CAGR of 7.1% from 2023 to 2032. The increasing prevalence of chronic diseases and gastrointestinal disorders, which often necessitate the use of parenteral nutrition, has significantly contributed to the market's expansion.

Parenteral Nutrition Market

To get key market trends

Download Free Sample

Additionally, the aging population and rising awareness about the importance of proper nutritional support have further fuelled demand for parenteral nutrition solutions. Technological advancements in healthcare and the development of innovative formulations and delivery methods have also played a pivotal role in this growth.

Parenteral Nutrition Market Report Attributes
Report Attribute	Details
Base Year:	2022
Parenteral Nutrition Market Size in 2022:	USD 5.7 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	7.1%
2032 Value Projection:	USD 11.1 Billion
Historical Data for:	2018 to 2022
No. of Pages:	289
Tables, Charts & Figures:	444
Segments covered:	Composition, Type, Consumer, End-user, and Region
Growth Drivers:	Increasing metabolic disorders and other chronic diseases Growing malnutrition across the globe Rise in geriatric population Increasing rate of pre-mature birth & birth rate Growing adoption of home healthcare settings in developed countries
Pitfalls & Challenges:	Lack of clinical evidence to support novel technology

Learn more about the key segments shaping this market

Download Free Sample

Parenteral nutrition, a component of clinical nutrition, also known as intravenous nutrition or total parenteral nutrition (TPN), is a medical technique that provides essential nutrients and fluids directly into a person's bloodstream. It is used when a patient is unable to obtain proper nutrition through oral or enteral (tube feeding) routes, often due to gastrointestinal issues, surgery, or other medical condition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Parenteral nutrition industry size was USD 5.7 billion in 2022 and is projected to record USD 11.2 million by 2032 due to the increasing prevalence of chronic diseases and gastrointestinal disorders across the world

The RTU/standard commercial parenteral nutrition industry held 88.3% revenue share in 2022 and is projected to experience 7% CAGR from 2023-2032 driven by immense popularity among healthcare professionals for reducing the need for on-site compounding and ensuring accurate nutrient delivery.

North America garnered 30% of the parenteral nutrition industry share in 2022 and is anticipated to expand at 7.2% CAGR through 2023 owing to the presence of well-established healthcare infrastructure in the region.

B. Braun Melsungen AG, Baxter International, Inc., Fresenius Kabi AG, OTSUKA HOLDINGS CO., LTD, Amanta Healthcare, Grifols International S.A., ICU Medical, Aculife Healthcare, AbbVie, Inc, and Aguettant are some of the major parenteral nutrition industry players.